Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.57 - $34.65 $3,790 - $230,422
-6,650 Reduced 31.58%
14,410 $13,000
Q2 2022

Aug 15, 2022

BUY
$0.85 - $1.41 $6,085 - $10,094
7,159 Added 51.5%
21,060 $20,000
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $17,003 - $36,645
-14,658 Reduced 51.33%
13,901 $20,000
Q4 2021

Feb 14, 2022

SELL
$2.46 - $8.74 $37,438 - $133,014
-15,219 Reduced 34.76%
28,559 $73,000
Q3 2021

Nov 12, 2021

SELL
$5.1 - $9.39 $50,688 - $93,327
-9,939 Reduced 18.5%
43,778 $365,000
Q1 2021

May 14, 2021

BUY
$2.01 - $5.55 $107,971 - $298,129
53,717 New
53,717 $249,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.